Menu
Recruiting NCT06245187

Get With the Guidelines Atrial Fibrillation Registry

Observational Atrial Fibrillation Atrial Flutter

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: GWTG Atrial Fibrillation program.
Who it may be relevant to
Registry conditions: Atrial Fibrillation, Atrial Flutter. Basic parameters: 18 years — 125 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Get With the Guidelines-Atrial Fibrillation

Overview

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Detailed description

Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation:

1. ACEI/ARB at discharge for LVSD 2. Assessment of thromboembolic risk factors 3. Beta Blocker at discharge 4. Discharged on FDA-approved anticoagulation therapy 5. PT/INR planned follow-up 6. Statin at discharge in AF patients with CAD, CVA/TIA or PVD.

Quality measures tracked through Get With The Guidelines-Atrial Fibrillation:

1. Aldosterone antagonist at discharge 2. Atrial fibrillation patient education 3. Anticoagulation therapy education 4. CHA2DS2-VASC reported 5. Discharge heart rate \<110bpm 6. Smoking cessation 7. Warfarin at discharge for valvular atrial fibrillation

Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloadable/ucm\_451183.pdf

Interventions

  • Other GWTG Atrial Fibrillation program
    Evidence based recommended therapies and counseling prior to hospital discharge.

Primary outcome measures

  • Cardiac Tamponade and/or Pericardiocentesis Following Ablation [Time frame: 30 days]

Eligibility criteria

Inclusion criteria

  • Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion criteria

  • Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
  • Patients under 18 years of age
  • Patients not admitted as inpatients.
  • Patients on comfort care only
  • Patients discharged to hospice.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Amy Bennett — Dallas

Publications

  • January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Car PMID 24685669

Identifiers

NCT: NCT06245187 · 002

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗